Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ingrid M. Bistervels"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
BackgroundPotential hazards of vena cava filters include migration, tilt, perforation, fracture, and in-filter thrombosis. Due to physiological changes during pregnancy, the incidence of these complications might be different in pregnant women.AimTo
Externí odkaz:
https://doaj.org/article/cea325e69bee42d2895779444d9f04cd
Autor:
Ingrid M. Bistervels, Roisin Bavalia, Jan Beyer‐Westendorf, Arina J. tenCate‐Hoek, Sebastian M. Schellong, Michael J. Kovacs, Nicolas Falvo, Karina Meijer, Dominique Stephan, Wim G. Boersma, Marije tenWolde, Francis Couturaud, Peter Verhamme, Dominique Brisot, Susan R. Kahn, Waleed Ghanima, Karine Montaclair, Amanda Hugman, Patrick Carroll, Gilles Pernod, Olivier Sanchez, Emile Ferrari, Pierre‐Marie Roy, Marie‐Antoinette Sevestre‐Pietri, Simone Birocchi, Hilde S. Wik, Barbara A. Hutten, Michiel Coppens, Christiane Naue, Michael A. Grosso, Minggao Shi, Yong Lin, Isabelle Quéré, Saskia Middeldorp, the Hokusai PTS Investigators
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 5, Pp n/a-n/a (2022)
Abstract Background Postthrombotic syndrome (PTS) is a long‐term complication after deep vein thrombosis (DVT) and can affect quality of life (QoL). Pathogenesis is not fully understood but inadequate anticoagulant therapy with vitamin K antagonist
Externí odkaz:
https://doaj.org/article/0df21bbe9243416c846a58adaeb27c35
Autor:
Roisin Bavalia, Ingrid M. Bistervels, Wim G. Boersma, Isabelle Quere, Dominique Brisot, Nicolas Falvo, Dominique Stephan, Francis Couturaud, Sebastian Schellong, Jan Beyer‐Westendorf, Karine Montaclair, Waleed Ghanima, Marije ten Wolde, Michiel Coppens, Emile Ferrari, Olivier Sanchez, Patrick Carroll, Pierre‐Marie Roy, Susan R. Kahn, Karina Meijer, Simone Birocchi, Michael J. Kovacs, Amanda Hugman, Hugo ten Cate, Hilde Wik, Gilles Pernod, Marie‐Antoinette Sevestre‐Pietri, Michael A. Grosso, Minggao Shi, Yong Lin, Barbara A. Hutten, Peter Verhamme, Saskia Middeldorp, the Hokusai post‐PE study investigators
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Abstract Background Long‐term sequelae of acute pulmonary embolism (PE) include decreased quality of life (QoL). Evidence suggests that adequacy of initial anticoagulant treatment in the acute phase of venous thrombosis has a key impact on late pos
Externí odkaz:
https://doaj.org/article/9d304d4f7ddc45cebfc27bba1df82c7c
Autor:
Ingrid M. Bistervels, Hanke M.G. Wiegers, Fionnuala Ní Áinle, Suzanne M. Bleker, Céline Chauleur, Jennifer Donnelly, Anne F. Jacobsen, Marc A. Rodger, Maria T. DeSancho, Peter Verhamme, Anette T. Hansen, Roman G. Shmakov, Wessel Ganzevoort, Andrea Buchmüller, Saskia Middeldorp
Publikováno v:
Journal of Thrombosis and Haemostasis, 21, 57-67
Bistervels, I M, Wiegers, H M G, Áinle, F N, Bleker, S M, Chauleur, C, Donnelly, J, Jacobsen, A F, Rodger, M A, DeSancho, M T, Verhamme, P, Hansen, A T, Shmakov, R G, Ganzevoort, W, Buchmüller, A, Middeldorp, S & Highlow Investigators 2023, ' Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin : insights from the Highlow study ', Journal of Thrombosis and Haemostasis, vol. 21, no. 1, pp. 57-67 . https://doi.org/10.1016/j.jtha.2022.11.004
Journal of Thrombosis and Haemostasis, 21, 1, pp. 57-67
Journal of thrombosis and haemostasis : JTH, 21(1), 57-67. Wiley-Blackwell
Bistervels, I M, Wiegers, H M G, Áinle, F N, Bleker, S M, Chauleur, C, Donnelly, J, Jacobsen, A F, Rodger, M A, DeSancho, M T, Verhamme, P, Hansen, A T, Shmakov, R G, Ganzevoort, W, Buchmüller, A, Middeldorp, S & Highlow Investigators 2023, ' Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin : insights from the Highlow study ', Journal of Thrombosis and Haemostasis, vol. 21, no. 1, pp. 57-67 . https://doi.org/10.1016/j.jtha.2022.11.004
Journal of Thrombosis and Haemostasis, 21, 1, pp. 57-67
Journal of thrombosis and haemostasis : JTH, 21(1), 57-67. Wiley-Blackwell
Item does not contain fulltext BACKGROUND: Peripartum management of women using low-molecular-weight heparin (LMWH) varies widely. Minimum time intervals are required between LMWH injection and neuraxial procedure, and they differ by dose. OBJECTIVES
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3654d189dac1bc9406534275cd70541
http://hdl.handle.net/2066/290874
http://hdl.handle.net/2066/290874
Autor:
Ingrid M Bistervels, Andrea Buchmüller, Hanke M G Wiegers, Fionnuala Ní Áinle, Bernard Tardy, Jennifer Donnelly, Peter Verhamme, Anne F Jacobsen, Anette T Hansen, Marc A Rodger, Maria T DeSancho, Roman G Shmakov, Nick van Es, Martin H Prins, Céline Chauleur, Saskia Middeldorp, Eline S van den Akker, Mireille N Bekker, Thomas van Bemmel, Laurent Bertoletti, Julie Blanc, Suzanne M Bleker, Aude Bourtembourg-Matras, Florence Bretelle, Bridgette Byrne, Francis Couturaud, Pierre Delorme, Elise S Eerenberg, Maureen TM Franssen, Jens Fuglsang, Wessel Ganzevoort, François Goffinet, Jiska M de Haan-Jebbink, Wieteke Heidema, Monique A Hertzberg, Marcel MC Hovens, Menno V Huisman, Leonie de Jong-Speksnijder, Pieter-Willem Kamphuisen, Denis J O'Keeffe, Karine Lacut, Josje Langenveld, M Simone Lunshof, Caroline P Martens, Adel Merah, Emmanuelle Le Moigne, Dimitri NM Papatsonis, Gilles Pernod, Franck Perrotin, Edith Peynaud-Debayle, Fabrice Pierre, Geneviève Plu Bureau, Tiphaine Raia-Barjat, Robbert JP Rijnders, Roger Rosario, Marc Ruivard, Jeannot Schmidt, Marieke Sueters, Thomas Vanassche, Marie-Noëlle Varlet, Alexandre J Vivanti, Matthieu Y van der Vlist, Lucet F van der Voet, Karlijn C Vollebregt, Johanna IP de Vries, Sabina de Weerd, Peter E Westerweel, Lia DE Wijnberger, Marije ten Wolde, Paula F Ypma, Catherine Zuily-Lamy, Joost J Zwart, Alexandra Benachi, Gaël Beucher, Holy Bezanahary, Karin de Boer, Marjon A. de Boer, Frantz Bousquet, Henk A. Bremer, Luc Bressollette, Aurélie Brossard, Cécile Chau, Brian Cleary, Fabienne Comte, Thomas Corsini, Anne Coustel, Barbara Debaveye, Raoul Desbrière, Cécile Duvillard, Astrid Eckman, Jeroen Eikenboom, Antoine Elias, Laura M. Faber, Emile Ferrari, Denis Gallot, Emilie Gauchotte, Ingrid Gaugler, Abby E. Geerlings, Audrey O'Gorman, Vincent Grobost, Pieter-Kees de Groot, David P. van der Ham, Brenda Hermsen, Kim Kamphorst, Alan Karovitch, Gunilla Kleiverda, Aiste Kloster, Annemarieke Koops, Inneke Krabbendam, Marieke J.H.A. Kruip, Saskia Kuipers, Judith van Laar, Damien Laneelle, Suzanne Lima, Peter MacMahon, Laurent Mandelbrot, Claudia A. van Meir, Caroline Menez, Leonard P. Morssink, Nathalie Moulin, Eve Mousty, Matthieu Muller, Lucy Murphy, Kathelijne Peerlinck, Alma O'Reilly, Maartje de Reus, Magali Hilmi Le Roux, Kevin Ryan, Bettina Samren, Daniela Schippers, Nico Schuitemaker, Chloé Schweizer, Hanneke van der Straaten, Cécile Tromeur, Kristine Vanheule, Tamara Verhagen, Jantien Visser, Michael Watts, Wim J. van Wijngaarden, Mallory Woiski, Maartje Zelis
Publikováno v:
The Lancet, 400(10365), 1777-1787. Elsevier Limited
Obstetrical and Gynecological Survey, 78(5), 259-261. Lippincott Williams and Wilkins
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S, Highlow Block writing committee & Highlow Investigators 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Lancet, 400(10365), 1777-1787. Elsevier Science
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C L, Highlow Block writing committee, Middeldorp, S, Highlow Investigators, van den Akker, E S, Bekker, M N, van Bemmel, T, Bertoletti, L, Blanc, J, Bleker, S M, Bourtembourg-Matras, A, Bretelle, F, Byrne, B, Couturaud, F, Delorme, P, Eerenberg, E S, Franssen, M T M, Fuglsang, J, Ganzevoort, W, Goffinet, F, de Haan-Jebbink, J M, Heidema, W, Hertzberg, M A, Hovens, M M C, Huisman, M V, de Jong-Speksnijder, L, Kamphuisen, P-W, O'Keeffe, D J, Lacut, K, Langenveld, J, Lunshof, M S, Martens, C P, Merah, A, le Moigne, E, Papatsonis, D N M, Pernod, G, Perrotin, F, Peynaud-Debayle, E, Pierre, F, Plu Bureau, G, Raia-Barjat, T, Rijnders, R J P, Rosario, R, Ruivard, M, Schmidt, J, Sueters, M, Vanassche, T, Varlet, M-N, Vivanti, A J, van der Vlist, M Y, van der Voet, L F, Vollebregt, K C, de Vries, J I P, de Weerd, S, Westerweel, P E, Wijnberger, L D E, ten Wolde, M, Ypma, P F, Zuily-Lamy, C, Zwart, J J, Benachi, A, Beucher, G, Bezanahary, H, de Boer, K, de Boer, M A, Bousquet, F, Bremer, H A, Bressollette, L, Brossard, A, Chau, C C, Cleary, B, Comte, F, Corsini, T, Coustel, A, Debaveye, B, Desbrière, R, Duvillard, C C, Eckman, A, Eikenboom, J, Elias, A, Faber, L M, Ferrari, E, Gallot, D, Gauchotte, E, Gaugler, I, Geerlings, A E, O'Gorman, A, Grobost, V, de Groot, P-K, van der Ham, D P, Hermsen, B, Kamphorst, K, Karovitch, A, Kleiverda, G, Kloster, A, Koops, A, Krabbendam, I, Kruip, M J H A, Kuipers, S, van Laar, J, Laneelle, D, Lima, S, MacMahon, P, Mandelbrot, L, van Meir, C A, Menez, C, Morssink, L P, Moulin, N, Mousty, E, Muller, M, Murphy, L, Peerlinck, K, O'Reilly, A, de Reus, M, le Roux, M H, Ryan, K, Samren, B, Schippers, D, Schuitemaker, N, Schweizer, C, van der Straaten, H, Tromeur, C C, Vanheule, K, Verhagen, T, Visser, J, Watts, M, van Wijngaarden, W J, Woiski, M & Zelis, M 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S & Fuglsang, J 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
The Lancet, 400(10365), 1777-1787. Elsevier Ltd.
The Lancet (London), 400, 1777-1787
The Lancet (London), 400, 10365, pp. 1777-1787
Obstetrical and Gynecological Survey, 78(5), 259-261. Lippincott Williams and Wilkins
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S, Highlow Block writing committee & Highlow Investigators 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Lancet, 400(10365), 1777-1787. Elsevier Science
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C L, Highlow Block writing committee, Middeldorp, S, Highlow Investigators, van den Akker, E S, Bekker, M N, van Bemmel, T, Bertoletti, L, Blanc, J, Bleker, S M, Bourtembourg-Matras, A, Bretelle, F, Byrne, B, Couturaud, F, Delorme, P, Eerenberg, E S, Franssen, M T M, Fuglsang, J, Ganzevoort, W, Goffinet, F, de Haan-Jebbink, J M, Heidema, W, Hertzberg, M A, Hovens, M M C, Huisman, M V, de Jong-Speksnijder, L, Kamphuisen, P-W, O'Keeffe, D J, Lacut, K, Langenveld, J, Lunshof, M S, Martens, C P, Merah, A, le Moigne, E, Papatsonis, D N M, Pernod, G, Perrotin, F, Peynaud-Debayle, E, Pierre, F, Plu Bureau, G, Raia-Barjat, T, Rijnders, R J P, Rosario, R, Ruivard, M, Schmidt, J, Sueters, M, Vanassche, T, Varlet, M-N, Vivanti, A J, van der Vlist, M Y, van der Voet, L F, Vollebregt, K C, de Vries, J I P, de Weerd, S, Westerweel, P E, Wijnberger, L D E, ten Wolde, M, Ypma, P F, Zuily-Lamy, C, Zwart, J J, Benachi, A, Beucher, G, Bezanahary, H, de Boer, K, de Boer, M A, Bousquet, F, Bremer, H A, Bressollette, L, Brossard, A, Chau, C C, Cleary, B, Comte, F, Corsini, T, Coustel, A, Debaveye, B, Desbrière, R, Duvillard, C C, Eckman, A, Eikenboom, J, Elias, A, Faber, L M, Ferrari, E, Gallot, D, Gauchotte, E, Gaugler, I, Geerlings, A E, O'Gorman, A, Grobost, V, de Groot, P-K, van der Ham, D P, Hermsen, B, Kamphorst, K, Karovitch, A, Kleiverda, G, Kloster, A, Koops, A, Krabbendam, I, Kruip, M J H A, Kuipers, S, van Laar, J, Laneelle, D, Lima, S, MacMahon, P, Mandelbrot, L, van Meir, C A, Menez, C, Morssink, L P, Moulin, N, Mousty, E, Muller, M, Murphy, L, Peerlinck, K, O'Reilly, A, de Reus, M, le Roux, M H, Ryan, K, Samren, B, Schippers, D, Schuitemaker, N, Schweizer, C, van der Straaten, H, Tromeur, C C, Vanheule, K, Verhagen, T, Visser, J, Watts, M, van Wijngaarden, W J, Woiski, M & Zelis, M 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
Bistervels, I M, Buchmüller, A, Wiegers, H M G, Ní Áinle, F, Tardy, B, Donnelly, J, Verhamme, P, Jacobsen, A F, Hansen, A T, Rodger, M A, DeSancho, M T, Shmakov, R G, van Es, N, Prins, M H, Chauleur, C, Middeldorp, S & Fuglsang, J 2022, ' Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study) : an open-label, multicentre, randomised, controlled trial ', The Lancet, vol. 400, no. 10365, pp. 1777-1787 . https://doi.org/10.1016/S0140-6736(22)02128-6
The Lancet, 400(10365), 1777-1787. Elsevier Ltd.
The Lancet (London), 400, 1777-1787
The Lancet (London), 400, 10365, pp. 1777-1787
Item does not contain fulltext BACKGROUND: Pregnancy-related venous thromboembolism is a leading cause of maternal morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum women with a history of venous thromboembolism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8643920b0d7863c0bf84cfcc765abbb7
https://research.vumc.nl/en/publications/3fcd7296-5482-402f-b3e2-cbcd907acec9
https://research.vumc.nl/en/publications/3fcd7296-5482-402f-b3e2-cbcd907acec9
Autor:
Ingrid M. Bistervels, Roisin Bavalia, Martin Gebel, Anthonie W.A. Lensing, Saskia Middeldorp, Martin H. Prins, Michiel Coppens
Publikováno v:
Journal of Thrombosis and Haemostasis, 20(6), 1376-1384. Wiley
Journal of Thrombosis and Haemostasis, 20, 6, pp. 1376-1384
Journal of thrombosis and haemostasis, 20(6), 1376-1384. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 20, 1376-1384
Journal of Thrombosis and Haemostasis, 20, 6, pp. 1376-1384
Journal of thrombosis and haemostasis, 20(6), 1376-1384. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 20, 1376-1384
Contains fulltext : 251904.pdf (Publisher’s version ) (Open Access) BACKGROUND: Polypharmacy, including use of inhibitors of CYP3A4 and P-glycoprotein (P-gp), is common in patients with venous thromboembolism (VTE) and is associated with increased
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f79365fbfc1a077cebae0237e3b9e475
https://cris.maastrichtuniversity.nl/en/publications/1e7914fb-f824-4a4b-b2e2-8d4f04294e74
https://cris.maastrichtuniversity.nl/en/publications/1e7914fb-f824-4a4b-b2e2-8d4f04294e74
Autor:
Saskia Middeldorp, Wessel Ganzevoort, Ingrid M. Bistervels, Peter I. Bonta, Ijsbrand A.J. Zijlstra, Abby E. Geerlings
Publikováno v:
Blood Advances, 5, 20, pp. 4044-4053
Blood Advances, 5, 4044-4053
Blood Advances, 5, 4044-4053
Contains fulltext : 245711.pdf (Publisher’s version ) (Open Access) Patients with an inferior vena cava (IVC) filter that remains in situ encounter a lifelong increased risk of deep vein thrombosis and IVC filter complications including fracture, p
Autor:
Bettina Kemkes-Matthes, Ingrid M. Bistervels, WE Paulus, Sandra Marten, Martin Bornhäuser, Luise Tittl, Saskia Middeldorp, Jan Beyer-Westendorf, Christof Schaefer, Will Thomas
Publikováno v:
Lancet. Haematology, 7(12), e884-e891. Lancet Publishing Group
Summary Background Direct oral anticoagulants (DOACs) have largely replaced vitamin K antagonists in many indications for anticoagulation. Prescribed to millions of patients, including women of reproductive age, exposure to DOACs in early pregnancy i
Autor:
Adel Merah, Peter Verhamme, Andrea Buchmuller, Pieter Willem Kamphuisen, Marie Noelle Varlet, Maria Teresa De Sancho, Ingrid M. Bistervels, Emilie Chalayer, Bernard Tardy, Céline Chauleur, Saskia Middeldorp, Fionnuala Ní Áinle, Marc A. Rodger, Laurent Bertoletti
Publikováno v:
Journal of thrombosis and haemostasis, 17(11), 1979-1988. Wiley-Blackwell
Autor:
Isabelle Quéré, Susan R. Kahn, Olivier Sanchez, Roisin Bavalia, Saskia Middeldorp, Karine Montaclair, Dominique Stephan, D. Brisot, Francis Couturaud, Sebastian Schellong, Minggao Shi, Michael A. Grosso, Patrick Carroll, Ingrid M. Bistervels, Jan Beyer-Westendorf, Peter Verhamme, Pierre-Marie Roy, Hilde Skuterud Wik, Hugo ten Cate, Nicolas Falvo, Karina Meijer, Yong Lin, Hokusai post‐PE study investigators, Marie-Antoinette Sevestre-Pietri, Michael J. Kovacs, Simone Birocchi, Waleed Ghanima, Emile Ferrari, Marije ten Wolde, Wim Boersma, Barbara A. Hutten, Michiel Coppens, Gilles Pernod, Amanda Hugman
Publikováno v:
Research and practice in thrombosis and haemostasis, 5(5):e12566. Wiley
Research and Practice in Thrombosis and Haemostasis
Research and practice in thrombosis and haemostasis, 5(5):12566. Wiley
Research and practice in thrombosis and haemostasis, 5(5):e12566. Wiley-Blackwell Publishing Ltd
Research and Practice in Thrombosis and Haemostasis, 5, 5
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Research and Practice in Thrombosis and Haemostasis, 5
Research and Practice in Thrombosis and Haemostasis
Research and practice in thrombosis and haemostasis, 5(5):12566. Wiley
Research and practice in thrombosis and haemostasis, 5(5):e12566. Wiley-Blackwell Publishing Ltd
Research and Practice in Thrombosis and Haemostasis, 5, 5
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 5, Pp n/a-n/a (2021)
Research and Practice in Thrombosis and Haemostasis, 5
BACKGROUND: Long-term sequelae of acute pulmonary embolism (PE) include decreased quality of life (QoL). Evidence suggests that adequacy of initial anticoagulant treatment in the acute phase of venous thrombosis has a key impact on late postthromboti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e9a85a7cef3f32c8db442003c1f0f83
https://lirias.kuleuven.be/handle/123456789/678582
https://lirias.kuleuven.be/handle/123456789/678582